JERUSALEM–(HSMN NewsFeed)–Teva Pharma Industries Ltd. (Nasdaq: TEVA ) announced today that several of its subsidiaries in the United States reached a settlement in principle to resolve claims brought by Ven-A-Care of the Florida Keys, Inc. on beh…
Biopharmaceuticals, Litigation
Teva Clinical, Ven-A-Care

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Teva Announces Settlement in Principle regarding Certain Drug Pricing Lawsuits”
Leave a Comment